Lv1
70 积分 2025-10-11 加入
Concurrent genetic and non-genetic resistance mechanisms to KRAS inhibition in colorectal cancer
1个月前
已完结
Targeting the epigenome and immune evasion: a new chapter in PRMT5 inhibition
4个月前
已关闭
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
4个月前
已完结
Abstract 389: GFH276: A molecular glue panRAS(on) inhibitor with broad spectrum anti-tumor activities
5个月前
已关闭
Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma
5个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
6个月前
已完结
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer
7个月前
已完结
Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism
9个月前
已完结
Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti–PD-1 Treatment
9个月前
已完结
Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
9个月前
已完结